Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 0 | 2,411 | 2,608 | 2,211 | 2,646 |
| Gross Profit | N/A | 2,411 | 2,608 | 2,211 | 2,646 |
| Operating Expenses | 778 | 7,415 | 10,088 | 9,840 | 8,634 |
| Operating Income | -778 | -5,004 | -7,480 | -7,629 | -5,988 |
| Interest Expense | 44 | 624 | 432 | 377 | 393 |
| Other Income | 2 | 19 | -508 | -16 | -33 |
| Pre-tax Income | -820 | -5,609 | -8,420 | -8,022 | -6,414 |
| Net Income Continuous | -820 | -5,609 | -8,420 | -8,022 | -6,414 |
| Net Income | $-820 | $-5,609 | $-8,420 | $-8,022 | $-6,414 |
| EPS Basic Total Ops | -1.31 | -2.74 | -4.08 | 278.87 | -3.12 |
| EPS Basic Continuous Ops | -1.31 | -2.74 | -4.11 | 278.87 | -3.14 |
| EPS Diluted Total Ops | -1.31 | -2.74 | -4.08 | 278.87 | -3.12 |
| EPS Diluted Continuous Ops | -1.31 | -2.74 | -4.11 | 278.87 | -3.14 |
| EBITDA(a) | $-930 | $-4,920 | $-7,396 | $-7,541 | $-5,922 |